It would help if they could get at least get their rating up to OTC Pink "Current Information" from where it currently is (OTC Pink "No Information"). Long-term, best to get off the pinks, but that will take awhile as they would have to meet both reporting requirements and price/valuation requirements. And of course, it is expensive thanks to Sarb-Ox. However, if they are successful, they could always evaluate whether it made sense to list on a non-US exchange. But all that is, hopefully, down the road. In the short-intermediate term, just getting to OTC Pink Current Information would be helpful. Remember, the pool of potential investors for a Pink Sheet stock is much smaller than the pool of potential investors for a stock that is on a more well-known/regulated exchange.